Nanomaterials promise better bone repair

Materials Today

Volumn 19, Issue 8, 2016, Pages 451-463

  Wang, Qifei ^a,b   Yan, Jianhua ^a   Yang, Junlin ^b   Li, Bingyun ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; NANOSTRUCTURED MATERIALS; REPAIR;

BONE FRACTURE; BONE REPAIR; GROWTH FACTOR; MOLECULAR LEVELS; STATE OF THE ART; THERAPEUTIC AGENTS; VASCULARIZATION;

FRACTURE;

EID: 84954285386     PISSN: 13697021     EISSN: 18734103     Source Type: Journal    
DOI: 10.1016/j.mattod.2015.12.003     Document Type: Review

References (57)

1. [1] Peran, M., et al. Functionalized nanostructures with application in regenerative medicine. Int. J. Mol. Sci. 13 (2012), 3847–3886.
2. [2] Tautzenberger, A., Kovtun, A., Ignatius, A., Nanoparticles and their potential for application in bone. Int. J. Nanomed. 7 (2012), 4545–4557.
3. [3] Zhang, Z.G., et al. Advances in bone repair with nanobiomaterials: mini-review. Cytotechnology 63 (2011), 437–443.
4. [4] Nair, M.B., et al. A triphasic ceramic-coated porous hydroxyapatite for tissue engineering application. Acta Biomater. 4 (2008), 173–181.
5. [5] Roco, M.C., Nanotechnology: convergence with modern biology and medicine. Curr. Opin. Biotechnol. 14 (2003), 337–346.
6. [6] Rosen, A.B., et al. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 25 (2007), 2128–2138.
7. [7] Wang, C., et al. Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles. Biomaterials 33 (2012), 4872–4881.
8. [8] Yi, C., et al. Gold nanoparticles promote osteogenic differentiation of mesenchymal stem cells through p38 MAPK pathway. ACS Nano 4 (2010), 6439–6448.
9. [9] Chen, H., et al. Multifaceted applications of nanomaterials in cell engineering and therapy. Biotechnol. Adv. 31 (2013), 638–653.
10. [10] Casanova, M., et al. Quantitative phenotyping of bone fracture repair: a review. Bonekey Rep., 3, 2014, 550.
11. [11] Miller, G.J., Gerstenfeld, L.C., Morgan, E.F., Mechanical microenvironments and protein expression associated with formation of different skeletal tissues during bone healing. Biomech. Model. Mechanobiol. 14 (2015), 1239–1253.
12. [12] Unger, R.E., Dohle, E., Kirkpatrick, C.J., Improving vascularization of engineered bone through the generation of pro-angiogenic effects in co-culture systems. Adv. Drug Deliv. Rev., 2015.
13. [13] Bartczak, D., et al. Manipulation of in vitro angiogenesis using peptide-coated gold nanoparticles. ACS Nano 7 (2013), 5628–5636.
14. [14] Kankilic, B., et al. Mesenchymal stem cells and nano-bioceramics for bone regeneration. Curr. Stem Cell Res. Ther., 2015.
15. [15] Ibrahim, N., Mohamed, N., Shuid, A.N., Update on statins: hope for osteoporotic fracture healing treatment. Curr. Drug Targets 14 (2013), 1524–1532.
16. [16] Fei, Y., Gronowicz, G., Hurley, M.M., Fibroblast growth factor-2, bone homeostasis and fracture repair. Curr. Pharm. Des. 19 (2013), 3354–3363.
17. [17] Giganti, M.G., et al. Fracture healing: from basic science to role of nutrition. Front. Biosci. (Landmark Ed.) 19 (2014), 1162–1175.
18. [18] Hausmann, M., et al. Use of bone morphogenetic proteins (BMPs) for the treatment of pseudarthroses – efficiency and therapy failure. Z. Orthop. Unfall. 152 (2014), 144–151.
19. [19] Bostrom, M.P., Expression of bone morphogenetic proteins in fracture healing. Clin. Orthop. Relat. Res., 1998, S116–S123.
20. [20] Patil, A.S., Sable, R.B., Kothari, R.M., An update on transforming growth factor-beta (TGF-beta): sources, types, functions and clinical applicability for cartilage/bone healing. J. Cell. Physiol. 226 (2011), 3094–3103.
21. [21] Zakrzewska, M., Marcinkowska, E., Wiedlocha, A., FGF-1: from biology through engineering to potential medical applications. Crit. Rev. Clin. Lab. Sci. 45 (2008), 91–135.
22. [22] Clarkin, C.E., Gerstenfeld, L.C., VEGF and bone cell signalling: an essential vessel for communication?. Cell Biochem. Funct. 31 (2013), 1–11.
23. [23] Graham, S., et al. Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin. Invest. Drug 18 (2009), 1633–1654.
24. [24] Sheng, M.H., Lau, K.H., Baylink, D.J., Role of osteocyte-derived insulin-like growth factor I in developmental growth, modeling, remodeling, and regeneration of the bone. J. Bone Metab. 21 (2014), 41–54.
25. [25] Olson, S.A., et al. The role of cytokines in posttraumatic arthritis. J. Am. Acad. Orthop. Surg. 22 (2014), 29–37.
26. [26] David, J.P., Schett, G., TNF and bone. Curr. Dir. Autoimmun. 11 (2010), 135–144.
27. [27] Mehta, M., et al. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv. Drug Deliv. Rev. 64 (2012), 1257–1276.
28. [28] Hankenson, K.D., Zimmerman, G., Marcucio, R., Biological perspectives of delayed fracture healing. Injury 45:Suppl. 2 (2014), S8–S15.
29. [29] Hak, D.J., et al. Delayed union and nonunions: epidemiology, clinical issues, and financial aspects. Injury 45:Suppl. 2 (2014), S3–S7.
30. [30] Victoria, G., et al. Bone stimulation for fracture healing: what's all the fuss?. Indian J. Orthop. 43 (2009), 117–120.
31. [31] Sterling, J.A., Guelcher, S.A., Biomaterial scaffolds for treating osteoporotic bone. Curr. Osteoporos. Rep. 12 (2014), 48–54.
32. [32] Vukicevic, S., et al. The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing. Int. Orthop. 38 (2014), 635–647.
33. [33] Puska, M., Aho, A.J., Vallittu, P.K., Biomaterials in bone repair. Duodecim 129 (2013), 489–496.
34. [34] Papaspyridakos, P., et al. A systematic review of biologic and technical complications with fixed implant rehabilitations for edentulous patients. Int. J. Oral Maxillofac. Implants 27 (2012), 102–110.
35. [35] Oryan, A., et al. Bone regenerative medicine: classic options, novel strategies, and future directions. J. Orthop. Surg. Res., 9, 2014, 18.
36. [36] Perez, R.A., et al. Naturally and synthetic smart composite biomaterials for tissue regeneration. Adv. Drug Deliv. Rev. 65 (2013), 471–496.
37. [37] Balasundaram, G., Storey, D.M., Webster, T.J., Novel nano-rough polymers for cartilage tissue engineering. Int. J. Nanomed. 9 (2014), 1845–1853.
38. [38] Zhang, K., et al. Electrospun silk fibroin-hydroxybutyl chitosan nanofibrous scaffolds to biomimic extracellular matrix. J. Biomater. Sci. Polym. Ed. 22 (2011), 1069–1082.
39. [39] Reddi, A.H., Morphogenetic messages are in the extracellular matrix: biotechnology from bench to bedside. Biochem. Soc. Trans. 28 (2000), 345–349.
40. [40] Luginbuehl, V., et al. Localized delivery of growth factors for bone repair. Eur. J. Pharm. Biopharm. 58 (2004), 197–208.
41. [41] Schwab, E.H., et al. Nanoscale control of surface immobilized BMP-2: toward a quantitative assessment of BMP-mediated signaling events. Nano Lett. 15 (2015), 1526–1534.
42. [42] Amini, A.A., Nair, L.S., Injectable hydrogels for bone and cartilage repair. Biomed. Mater. 7 (2012), 024105–24113.
43. [43] Furuya, H., Tabata, Y., Kaneko, K., Bone regeneration for murine femur fracture by gelatin hydrogels incorporating basic fibroblast growth factor with different release profiles. Tissue Eng. Pt. A 20 (2014), 1531–1541.
44. [44] Mammadov, R., et al. Heparin mimetic peptide nanofibers promote angiogenesis. Biomacromolecules 12 (2011), 3508–3519.
45. [45] Riegler, J., et al. Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury. Biomaterials 34 (2013), 1987–1994.
46. [46] Henstock, J.R., et al. Remotely activated mechanotransduction via magnetic nanoparticles promotes mineralization synergistically with bone morphogenetic protein 2: applications for injectable cell therapy. Stem Cells Transl. Med. 3 (2014), 1363–1374.
47. [47] Wu, Y., et al. A novel calcium phosphate ceramic-magnetic nanoparticle composite as a potential bone substitute. Biomed. Mater., 5, 2010, 15001.
48. [48] Meng, J., et al. Paramagnetic nanofibrous composite films enhance the osteogenic responses of pre-osteoblast cells. Nanoscale 2 (2010), 2565–2569.
49. [49] Panseri, S., et al. Innovative magnetic scaffolds for orthopedic tissue engineering. J. Biomed. Mater. Res. A 100 (2012), 2278–2286.
50. [50] Bock, N., et al. A novel route in bone tissue engineering: magnetic biomimetic scaffolds. Acta Biomater. 6 (2010), 786–796.
51. [51] Armstead, A.L., Li, B., Nanomedicine as an emerging approach against intracellular pathogens. Int. J. Nanomed. 6 (2011), 3281–3293.
52. [52] Wang, X., Ding, B., Li, B., Biomimetic electrospun nanofibrous structures for tissue engineering. Mater. Today (Kidlington) 16 (2013), 229–241.
53. [53] Armstead, A.L., Arena, C.B., Li, B., Exploring the potential role of tungsten carbide cobalt (WC–Co) nanoparticle internalization in observed toxicity toward lung epithelial cells in vitro. Toxicol. Appl. Pharmacol. 278 (2014), 1–8.
54. [54] Oberdorster, G., Oberdorster, E., Oberdorster, J., Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113 (2005), 823–839.
55. [55] Zhen-bo, M., Yang, X., Ming-yuan, L., Physical damage – the origin of nanotoxicity. Chin. J. Pharmacol. Toxicol. 2 (2014), 154–160.
56. [56] Liu, L.Z., et al. Tungsten carbide-cobalt nanoparticles induce reactive oxygen species, AKT, ERK, AP-1, NF-kappaB, VEGF, and angiogenesis. Biol. Trace Elem. Res. 166 (2015), 57–65.
57. [57] Armstead, A.L., et al. Acute inflammatory responses of nanoparticles in an intra-tracheal instillation rat model. PLOS ONE, 10, 2015, e0118778.